SeraGene Therapeutics is a biotech company located in Vancouver, BC, that focuses on developing low treatment burden RNA-based therapies for a broad range of blood coagulation disorders. They utilize deep expertise in nanomedicine and clotting biology with the aim of improving patient lives by reducing the frequency and severity of bleeding or clotting events.